 The current state of pharmacovigilance in Iran is unsatisfactory due to lack of resources and priority given to this area. The country needs to allocate more resources and focus on improving the reporting of adverse drug reactions as well as increasing awareness among healthcare professionals about the importance of pharmacovigilance. This article was authored by Malahat Khalili, Hamid Sharifi, Bita Mesgarpur, and others.